V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003191 | 330001676 | 1.65 | 58.4 | null | 2014-04-11 | 2014-04-12 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012379 | CARBOPLATIN + PACLITAXEL |
| 330003192 | 330001676 | 1.74 | 83.3 | Palliative (P) | 2017-05-15 | 2017-06-10 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330012379 | LIPOSOMAL DOXORUBICIN |
| 330003193 | 330001676 | 1.7 | 58.5 | Disease modification (D) | 2014-07-30 | 2014-08-25 | Bendamustine+Rituximab (1st Course) | 2 | Y | 330012379 | BENDAMUSTINE + RITUXIMAB |
| 330003194 | 330001676 | 1.57 | 61.9 | Palliative (P) | 2014-09-16 | 2014-09-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330012379 | CARBOPLATIN + PACLITAXEL |
| 330003195 | 330001677 | 1.61 | 67.75 | Curative (C) | 2015-01-15 | 2015-01-15 | Liposomal Doxorubicin (Caelyx) | 02 | null | 330012387 | LIPOSOMAL DOXORUBICIN |
| 330003196 | 330001678 | 1.57 | 105.3 | Neo-adjuvant (N) | 2014-06-25 | 2014-07-08 | Cisplatin + Doxorubicin | 02 | N | 330012388 | CISPLATIN + DOXORUBICIN |
| 330003197 | 330006894 | null | 63.6 | null | 2017-06-24 | 2017-07-06 | Rituximab | N | N | 330012389 | RITUXIMAB |
| 330003198 | 330001679 | 1.83 | 62.5 | Not known (9) | 2017-02-11 | 2017-02-11 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330012390 | LIPOSOMAL DOXORUBICIN |
| 330003199 | 330001679 | 1.77 | 84.6 | Palliative (P) | 2014-02-25 | 2014-02-25 | Carboplatin AUC 6 - 10 | 02 | N | 330012390 | CARBOPLATIN |
| 330003200 | 330001679 | 1.62 | 61.8 | Disease modification (D) | 2014-10-23 | 2014-10-23 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330012390 | LIPOSOMAL DOXORUBICIN |
| 330003201 | 330001679 | 1.61 | 81.9 | Not known (9) | 2018-07-09 | 2018-07-09 | Doxorubicin 75mg/m2 | 02 | N | 330012390 | DOXORUBICIN |
| 330003202 | 330001679 | 1.62 | 79.5 | Disease modification (D) | 2018-07-17 | 2018-07-23 | BENDAMUSTINE + RITUXIMAB | N | N | 330012390 | BENDAMUSTINE + RITUXIMAB |
| 330003203 | 330001679 | 1.85 | 70 | Palliative (P) | 2013-06-07 | 2013-06-10 | Cisplatin + Doxorubicin | 02 | N | 330012390 | CISPLATIN + DOXORUBICIN |
| 330003204 | 330001679 | 1.59 | 82.6 | Curative (C) | null | 2015-11-04 | CARBOPLATIN | null | null | 330012390 | CARBOPLATIN |
| 330003205 | 330001679 | 1.7 | 61 | Neo-adjuvant (N) | 2013-04-12 | 2013-05-11 | Cisplatin + Doxorubicin | N | N | 330012390 | CISPLATIN + DOXORUBICIN |
| 330003206 | 330013215 | 1.61 | 56.2 | Neo-adjuvant (N) | 2016-10-30 | 2016-11-05 | Cisplatin + Doxorubicin | 01 | N | 330012404 | CISPLATIN + DOXORUBICIN |
| 330003207 | 330013273 | 1.86 | 67 | null | 2015-02-10 | 2015-02-12 | Rituximab | 02 | null | 330012405 | RITUXIMAB |
| 330003213 | 330001680 | 1.74 | 62.5 | Neo-adjuvant (N) | 2014-06-02 | 2014-06-14 | CARBOPLATIN + ETOPOSIDE | 02 | N | 330012412 | CARBOPLATIN + ETOPOSIDE |
| 330003214 | 330001681 | 1.8 | 54.7 | null | 2013-06-30 | 2013-07-12 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 330012413 | CARBOPLATIN + PACLITAXEL |
| 330003215 | 330001681 | 1.55 | 56 | Adjuvant (A) | 2014-10-26 | 2014-10-29 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 330012413 | CARBOPLATIN + PACLITAXEL |
| 330003216 | 330001682 | null | 70 | Adjuvant (A) | 2017-07-04 | 2017-07-16 | Rituximab | 02 | N | 330012418 | RITUXIMAB |
| 330003217 | 330001683 | 1.57 | 34.8 | Disease modification (D) | 2014-01-18 | 2014-01-18 | CARBOPLATIN + PACLITAXEL | 2 | N | 330012420 | CARBOPLATIN + PACLITAXEL |
| 330003218 | 330001683 | 1.85 | 61.9 | Curative (C) | 2016-07-05 | 2016-07-11 | Liposomal Doxorubicin (20mg/m2) | 2 | null | 330012420 | LIPOSOMAL DOXORUBICIN |
| 330003220 | 330006898 | 1.78 | 108.2 | Disease modification (D) | 2016-05-30 | 2016-05-31 | Bendamustine+Rituximab (1st Course) | N | N | 330012425 | BENDAMUSTINE + RITUXIMAB |
| 330003221 | 330009723 | 1.62 | 86 | Adjuvant (A) | 2014-11-22 | 2014-11-30 | Cisplatin + Doxorubicin | 2 | N | 330012426 | CISPLATIN + DOXORUBICIN |
| 330003222 | 330009723 | 1.5 | 46.8 | null | 2013-09-23 | 2013-09-26 | Liposomal Doxorubicin (Caelyx) | 02 | null | 330012426 | LIPOSOMAL DOXORUBICIN |
| 330003223 | 330009723 | 1.62 | null | Palliative (P) | 2014-04-16 | 2014-05-24 | Doxorubicin 75mg/m2 | 2 | N | 330012426 | DOXORUBICIN |
| 330003224 | 330001685 | 1.61 | 0 | null | 2017-12-10 | 2018-01-28 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330012431 | BENDAMUSTINE + RITUXIMAB |
| 330003225 | 330001685 | 1.67 | 63 | Unknown (U) | 2016-05-02 | 2016-05-05 | Rituximab | 02 | Y | 330012431 | RITUXIMAB |
| 330003226 | 330001685 | 1.75 | 71 | Curative (C) | 2017-04-28 | 2017-04-29 | Liposomal Doxorubicin (Caelyx) | N | N | 330012431 | LIPOSOMAL DOXORUBICIN |
| 330003227 | 330001686 | 1.56 | null | Curative (C) | 2014-12-24 | 2015-01-04 | Carboplatin + Etoposide IV 3 day | N | N | 330012434 | CARBOPLATIN + ETOPOSIDE |
| 330003228 | 330006900 | 1.64 | 38 | Neo-adjuvant (N) | 2016-10-11 | 2016-10-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | 330012436 | CARBOPLATIN + ETOPOSIDE |
| 330003229 | 330001687 | 1.91 | 76 | Palliative (P) | 2018-05-26 | 2018-05-29 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012437 | CARBOPLATIN + PACLITAXEL |
| 330003230 | 330001687 | null | 155 | Palliative (P) | 2016-09-08 | 2016-09-08 | BENDAMUSTINE + RITUXIMAB | N | N | 330012437 | BENDAMUSTINE + RITUXIMAB |
| 330003231 | 330001687 | 1.63 | 56.65 | null | 2014-04-28 | 2014-04-30 | Cisplatin + Doxorubicin | N | N | 330012437 | CISPLATIN + DOXORUBICIN |
| 330003232 | 330001688 | 1.47 | 51.9 | Palliative (P) | 2015-03-17 | 2015-03-18 | DOXORUBICIN | 02 | N | 330012442 | DOXORUBICIN |
| 330003233 | 330006902 | 1.64 | 68.8 | Palliative (P) | 2017-09-13 | 2017-09-21 | Cisplatin + Doxorubicin | 02 | N | 330012445 | CISPLATIN + DOXORUBICIN |
| 330003234 | 330006902 | 1.82 | 60 | Palliative (P) | null | 2015-09-20 | Doxorubicin 75mg/m2 | null | null | 330012445 | DOXORUBICIN |
| 330003235 | 330006902 | 1.67 | 58.7 | Palliative (P) | 2016-05-17 | 2016-05-18 | Bendamustine+Rituximab (1st Course) | N | N | 330012445 | BENDAMUSTINE + RITUXIMAB |
| 330003236 | 330006902 | 1.52 | 77.2 | Adjuvant (A) | 2013-06-20 | 2013-06-28 | Carboplatin + Etoposide IV 3 day | N | Y | 330012445 | CARBOPLATIN + ETOPOSIDE |
| 330003239 | 330001690 | 1.78 | 74 | Palliative (P) | 2015-03-05 | 2015-03-06 | Cisplatin + Doxorubicin | 2 | N | 330012451 | CISPLATIN + DOXORUBICIN |
| 330003240 | 330006904 | 1.77 | 68.3 | null | 2017-11-17 | 2017-11-17 | Cisplatin + Doxorubicin | 2 | N | 330012452 | CISPLATIN + DOXORUBICIN |
| 330003241 | 330001691 | 1.8 | 56 | Palliative (P) | 2013-11-19 | 2013-12-10 | CARBOPLATIN + ETOPOSIDE | N | N | 330012454 | CARBOPLATIN + ETOPOSIDE |
| 330003242 | 330001692 | 1.57 | 64 | Curative (C) | 2013-11-16 | 2013-11-26 | Liposomal Doxorubicin (Caelyx) | N | N | 330012455 | LIPOSOMAL DOXORUBICIN |
| 330003243 | 330006905 | 1.66 | 72.8 | null | 2017-05-23 | 2017-06-06 | Cisplatin + Doxorubicin | N | N | 330012458 | CISPLATIN + DOXORUBICIN |
| 330003244 | 330001693 | 1.8 | 78 | Palliative (P) | 2014-01-05 | 2014-01-05 | Liposomal Doxorubicin (20mg/m2) | 01 | N | 330012460 | LIPOSOMAL DOXORUBICIN |
| 330003246 | 330001694 | 1.72 | 84.8 | Palliative (P) | 2017-11-20 | 2017-12-09 | Carboplatin + Etoposide IV 3 day | N | N | 330012465 | CARBOPLATIN + ETOPOSIDE |
| 330003247 | 330001695 | 1.57 | 87 | Palliative (P) | 2016-07-27 | 2016-08-02 | Cisplatin + Doxorubicin | 02 | N | 330012466 | CISPLATIN + DOXORUBICIN |
| 330003248 | 330006907 | 1.55 | 74.3 | null | 2014-06-09 | 2014-06-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330012467 | CARBOPLATIN + PACLITAXEL |
| 330003249 | 330006907 | null | 97 | Curative (C) | null | 2013-09-17 | Rituximab | null | null | 330012467 | RITUXIMAB |